Registration for a live webinar on 'Precision medicine treatment for anticancer drug resistance' is now open.
See webinar detailsWe noted you are experiencing viewing problems
-
Check with your IT department that JWPlatform, JWPlayer and Amazon AWS & CloudFront are not being blocked by your network. The relevant domains are *.jwplatform.com, *.jwpsrv.com, *.jwpcdn.com, jwpltx.com, jwpsrv.a.ssl.fastly.net, *.amazonaws.com and *.cloudfront.net. The relevant ports are 80 and 443.
-
Check the following talk links to see which ones work correctly:
Auto Mode
HTTP Progressive Download Send us your results from the above test links at access@hstalks.com and we will contact you with further advice on troubleshooting your viewing problems. -
No luck yet? More tips for troubleshooting viewing issues
-
Contact HST Support access@hstalks.com
-
Please review our troubleshooting guide for tips and advice on resolving your viewing problems.
-
For additional help, please don't hesitate to contact HST support access@hstalks.com
We hope you have enjoyed this limited-length demo
This is a limited length demo talk; you may
login or
review methods of
obtaining more access.
Printable Handouts
Navigable Slide Index
- Introduction
- Objectives
- Overview
- MDR consolidated negotiated text (1)
- MDR consolidated negotiated text (2)
- MDR consolidated negotiated text (3)
- Options
- Business implications of MDR
- General obligations of the manufacturer
- Obligations of distributors
- Making available of devices
- Common specifications
- Identification and traceability of devices (1)
- Label and labeling
- More on labeling requirements
- Identification and traceability of devices (2)
- Who can issue UDIs?
- UDI / EUDAMED registration
- UDI / EUDEMED requirements
- More on UDI
- Notified bodies
- Reduced notified body capacity
- From MDR preamble
- Requirements of notified body
- Monitoring of notified bodies
- Safety & clinical performance reports (1)
- Safety & clinical performance reports (2)
- Summary report – notified body
- Confidentiality and quality management system
- Application process to notified body
- Distributors, AR and importers
Topics Covered
- Overview of MDR
- Transitioning from the MDD to the MDR
- Notified Body Requirements
- Interactions with Notified Bodies
- UDI
- Impact on EC Certifications
Talk Citation
Chatwin, L. (2017, August 31). Understanding transition from MDD to MDR [Video file]. In The Biomedical & Life Sciences Collection, Henry Stewart Talks. Retrieved December 27, 2024, from https://doi.org/10.69645/AHGU5285.Export Citation (RIS)
Publication History
Financial Disclosures
- Ms. Linda Chatwin has not informed HSTalks of any commercial/financial relationship that it is appropriate to disclose.
A selection of talks on Pharmaceutical Sciences
Transcript
Please wait while the transcript is being prepared...
0:00
Hello this is Linda Chatwin and we're going to be talking today about Understanding
the Transition from the Medical Device Directive to the Medical Device Regulation.
0:11
So today our objectives are to go through an overview of
the Medical Device Regulation and then understand
some steps in transitioning from the Medical Device Directive to the Regulation.
We'll talk a little bit about what the notified body requirements are going to be
under this new regulation and how you need to think
about your interactions with the notified bodies.
We'll talk about the UDI being a requirement in the regulation and what
the impact will be on EC certifications.
0:45
So, for an overview,
the regulation was published on May 5th,
this year, and it actually contains about 12 pages of preamble.
Being an attorney, the preamble is quite important to me and it
really contains a lot of information about the rationale of the regulation.
There are 175 pages, including 17 annexes,10 chapters with 123 articles.
Article 123 covers the entry into force and the date of application for the regulation.
So entry into force was on May 26 of this year.
The date of application, meaning,
the last date when everyone must transition to the regulation is May 26, 2020.
The notified body designation can begin in November 17th of this year,
and there are some confidentiality requirements under
the regulation that will go into effect on May 26, 2018.
And finally there's the number of provisions having to do with the EUDAMED database,
which is not actually ready yet.